Genomics Inform.
2017 Mar;15(1):2-10. 10.5808/GI.2017.15.1.2.
Evaluation of Digital PCR as a Technique for Monitoring Acute Rejection in Kidney Transplantation
- Affiliations
-
- 1Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul 05505, Korea. cookie_jklee@hotmail.com
- 2Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
- 3Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Korea. lshkidney@khu.ac.kr
- KMID: 2375579
- DOI: http://doi.org/10.5808/GI.2017.15.1.2
Abstract
- Early detection and proper management of kidney rejection are crucial for the long-term health of a transplant recipient. Recipients are normally monitored by serum creatinine measurement and sometimes with graft biopsies. Donor-derived cell-free deoxyribonucleic acid (cfDNA) in the recipient's plasma and/or urine may be a better indicator of acute rejection. We evaluated digital PCR (dPCR) as a system for monitoring graft status using single nucleotide polymorphism (SNP)-based detection of donor DNA in plasma or urine. We compared the detection abilities of the QX200, RainDrop, and QuantStudio 3D dPCR systems. The QX200 was the most accurate and sensitive. Plasma and/or urine samples were isolated from 34 kidney recipients at multiple time points after transplantation, and analyzed by dPCR using the QX200. We found that donor DNA was almost undetectable in plasma DNA samples, whereas a high percentage of donor DNA was measured in urine DNA samples, indicating that urine is a good source of cfDNA for patient monitoring. We found that at least 24% of the highly polymorphic SNPs used to identify individuals could also identify donor cfDNA in transplant patient samples. Our results further showed that autosomal, sex-specific, and mitochondrial SNPs were suitable markers for identifying donor cfDNA. Finally, we found that donor-derived cfDNA measurement by dPCR was not sufficient to predict a patient's clinical condition. Our results indicate that donor-derived cfDNA is not an accurate predictor of kidney status in kidney transplant patients.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Long term clinical benefits of pancreas-transplantation after kidney transplantation in patients with diabetes who had received kidney transplantation
- Monitoring of Mycophenolic Acid Trough Concentration in Kidney Transplant under Cyclosporine Is Beneficial in Reducing Acute Rejection within 1 Year
- Does the timing of acute rejection matter with the graft outcome in kidney transplantation?
- Noninvasive monitoring of mouse renal allograft rejection using micro-CT
- A Retrospective Analysis on Reasons for Allograft Nephrectomy after Kidney Transplantation
